TITRATION OF LIPID LOWERING THERAPY AFTER LIPOPROTEIN (A) MEASUREMENT IN BLACK VS. WHITE INDIVIDUALS IN THE AHA LP(A) COHORT AHA-LP(A)队列中黑人与白人测量脂蛋白(A)后的降脂治疗滴定 PHYSICIAN PRESCRIBING PATTERNS, PERCEPTIONS AND KNOWLED...
TITRATION OF LIPID LOWERING THERAPY AFTER LIPOPROTEIN (A) MEASUREMENT IN BLACK VS. WHITE INDIVIDUALS IN THE AHA LP(A) COHORT AHA-LP(A)队列中黑人与白人测量脂蛋白(A)后的降脂治疗滴定 PHYSICIAN PRESCRIBING PATTERNS, PERCEPTIONS AND KNOWLED...
2023CCD指 [4] Cardiology,ASPC)、美国国家血脂协会(National南对该定义的阐述主要突出体现稳定和CCD的特点, LipidAssociation,NLA)以及美国心血管预防护理学会反映了冠状动脉疾病患者从急性到慢性的连续过程,适 (PreventiveCardiovascularNursesAssociation,PCNA)用于门诊环境中。同时有益于指导我国基层医疗卫生机 联合发布了...
ACC 2024: Clinical Impact of New Data in Lipid Management Lipid Management Clinical Practice Guidelines (CFP-MFC, 2023) news Lipids and Dementia: A Complex and Evolving Story news Low Lipids Linked to Thyroid Cancer Recurrence news The Management of Anxiety in Primary Care news Six Updates...
2023年7月美国心脏协会(American Heart Association,AHA)、美国心脏病学会(American College of Cardiology,ACC)、美国胸科医师学会(American College of Chest Physicians,ACCP)、美国心脏病预防学会(American Society for Preventive Cardiology,ASPC)、美国国家血脂协会(National Lipid Association,NLA)以及美国心血管预防护...
Statins remain first-line therapy for lipid lowering in patients with CCD. For select patient groups, several adjunctive therapies, such as ezetimibe, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, inclisiran, or bempedoic acid, may be used. Note, however, that clinical outcomes...
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med, 2008, 359(13): 1343-1356. 15. Patel PA, Bavaria JE, Ghadimi K, et al. Aortic regurgitation in acute type-A aortic dissection: a clinical classifification for the perioperative echocardiographer in ...
Introduction: The 2013 ACC/AHA cholesterol treatment guidelines removed the recommendation to treat to blood cholesterol goals for adults with risk of ASCVD. We anticipated that the frequency of lipid testing would decline as a result. To test this hypothesis, we evaluated the frequency of LDL-C ...
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators N Engl J Med, 341 (1999), pp. 70-76 View in ScopusGoogle Scholar 60 B.R. Chaitman, R.M. Hardison, D. Adler, et al. The Bypass Angioplasty...
Bruce M. Psaty, MD, PhD1,2;Noel S. Weiss, MD, DrPH3 Author Affiliations JAMA.2014;311(5):461-462. doi:10.1001/jama.2013.284203 FullText In 1984, the Lipid Research Clinics Program trial provided modest, if controversial, evidence that cholestyramine was associated with a reduction in the...